We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Imutex alone justifies the share price at least twice over, at very least.
Then you have all the other arms. CF has done an incredible job. A CEO is judged on his capital allocation skills and the results from it. Friel is top draw. The institutions stuffing his pockets to get in - confirms this.
They are not buying for a double. They are buying for multiples in a one to two year period. Look at your account in nine months and you will say I wish I could be so stupid on all investments.
If/ when the contracts are signed with the big pharmas at £6-7 million a go, the sp will increase on each of those pieces of news. I would say Significantly given the small market cap but I do not want to be seen as a ramper.
This is by far my best share holding.
This is not going to boom unless positive Imutex news comes out of the blue, but the SP will just possibly grind slowly higher on contract news, let the day traders do their thing but I'm keeping my eye on the real prize..
sogamia:
thumbs up.
My friend let’s see where the sp is in a week. This is an investment not a trade.
Badshah13, the entry and exit prices are all you need focus on.
ATM everything points to higher prices to come. early days.
I am disappointed with my purchase today. Already 8% down as I got in at the spike.
But I am hoping this will eventually go lot higher than 16p.
Well, we win some and we lose some
GLA
The CEO is focused on growing the company and delivering good results for the share holders. I've been happy with what he's done so far.
I'm not expecting any wild share price movements, just steady growth.
I comfortable enough that I don't really follow what's going on. I only checked in here because I saw ORPH mentioned on another board and had a little trip over here to see that we're up! Lovely.
See you all in another few weeks!
Good luck.
I am all in now so fingers crossed
It is BOOM, BOOM TIME!
I am hoping I haven't got spiked into this. Haven't done much research and invested based on the investor presentation yesterday